TrumpRX Offers Limited Prescription Drug Discounts, Data Shows

New government-backed platform has low awareness and limited scope compared to existing options like GoodRx.

Mar. 18, 2026 at 10:21am

Got story updates? Submit your updates here. ›

A recent healthcare poll shows only a third of surveyed Americans have heard of the new TrumpRX prescription drug discount platform, and an even smaller percentage have visited the website. While TrumpRX offers discounts on some name-brand medications, it lacks the breadth of drugs available on competitors like GoodRx and the discounts may already be attainable through other manufacturer programs.

Why it matters

With 60% of Americans worried about prescription drug affordability, new platforms like TrumpRX aim to provide savings. However, the limited scope and awareness of TrumpRX suggests it may not significantly impact the broader issue of high drug prices that many Americans face.

The details

TrumpRX is a government-backed platform similar to GoodRX that offers discounted prescription drugs through a coupon model. As of launch, it lists 54 name-brand medications, lacking the nearly 1,000 drugs, including generics, available on GoodRX. Experts note that many of the discounts on TrumpRX are already attainable through existing manufacturer programs, and the platform mainly benefits those without insurance, with high deductibles, or wanting to pay cash for name-brand drugs out-of-pocket.

  • TrumpRX was launched in February 2026.
  • A recent healthcare poll was conducted in March 2026.

The players

TrumpRX

A government-backed prescription drug discount platform similar to GoodRX.

GoodRX

A private prescription drug discount platform that offers coupons for nearly 1,000 medications, including both name-brand and generic drugs.

Nitzan Arad

An Area Lead for Drug Pricing and Competition Policy with the Duke-Margolis Institute for Health Policy.

Got photos? Submit your photos here. ›

What they’re saying

“Many of the drugs already had existing manufacturer self pay programs with similar cash prices before the Trump RX launched, meaning consumers could already fund those prices by going directly to the manufacturer or by using GoodRx for certain drugs. And what TrumpRX does basically kind of aggregate all those channels and all those places into kind of one portal that can be used by consumers.”

— Nitzan Arad, Area Lead for Drug Pricing and Competition Policy, Duke-Margolis Institute for Health Policy

“Another point to mention here is that paying cash through TrumpRX or other platforms typically doesn't count towards deductibles and annual out of pocket limits, which is a key protection for patients with especially those with high drug use or multiple prescriptions.”

— Nitzan Arad, Area Lead for Drug Pricing and Competition Policy, Duke-Margolis Institute for Health Policy

The takeaway

While TrumpRX aims to provide prescription drug savings, its limited scope, low awareness, and inability to count towards insurance deductibles suggest it may have a minimal impact on the broader issue of high drug prices that many Americans face.